Patent assignee · SE · COMPANY

PREMACURE AB

2Patents
2Active
2Granted
38Portfolio score

Filing activity: Apr 18, 2008 → Feb 9, 2015 · 1 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8518877B2 Method and product for treatment and/or prevention of complications of prematurity Human Necessities 0 Active
US9463222B2 Methods for treatment of complications of prematurity comprising administration of IGF-I and IGFBP-3 Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.